Xenome
closedXenome, a biopharmaceutical company, developed a therapeutic product for the management of moderate to severe pain.
Employees
Enterprise value
$32—48m
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
$8.0m | Early VC | ||
| Total Funding | 000k | ||
Notes (0)
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads